Madrigal Pharmaceuticals Inc
$333.91
(as of Apr 30, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Madrigal Pharmaceuticals Inc
Stock Price
$333.91
Ticker Symbol
MDGL
Exchange
NASDAQ
Industry Information for Madrigal Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Company Description for Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Fundamentals for Madrigal Pharmaceuticals Inc
Market Capitalization
$7,314,949,632
EBITDA
$-496,779,008
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-21.90
Earnings per Share Estimate Next Year
Profit Margin
-258.64%
Shares Outstanding
22,080,200
Percent Owned by Insiders
8.79%
Percent Owned by Institutions
105.14%
52-Week High
52-Week Low
Technical Indicators for Madrigal Pharmaceuticals Inc
Analyst Ratings for Madrigal Pharmaceuticals Inc
Strong Buy
10
Buy
4
Hold
1
Sell
1
Strong Sell
0
News About Madrigal Pharmaceuticals Inc
Apr 29, 2025, 8:00 AM EST
Madrigal Pharmaceuticals, Inc.
See more.
Apr 28, 2025, 1:38 PM EST
As U.S. stock markets experience fluctuations with key indices like the S&P 500 and Dow Jones Industrial Average losing ground after a recent winning streak, investors are closely watching earnings reports and economic indicators, including GDP data and inflation readings. See more.
Apr 18, 2025, 8:00 AM EST
CONSHOHOCKEN, Pa., April 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. See more.
Apr 18, 2025, 8:00 AM EST
Madrigal Pharmaceuticals, Inc.
See more.